Novavax Advances Development of Novel COVID-19 Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. VEON

Go back to Novavax Advances Development of Novel COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.63 +0.03 (0.28%)
Previous Close $10.60    52 Week High $9.23 
Open $10.62    52 Week Low $1.16 
Day High $10.79    P/E N/A 
Day Low $10.34    EPS $-0.30 
Volume 3,910,064